NAD+ comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-03-11. Where a claim depends on a specific study, the study is described rather than over-claimed.
In the salvage pathway, NMN is generated from nicotinamide and 5-phosphoribosyl-1-pyrophosphate by the enzyme nicotinamide phosphoribosyltransferase. A second route produces NMN from nicotinamide riboside through phosphorylation by nicotinamide riboside kinases. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases, often called NMNAT enzymes. This stepwise route allows cells to recycle nicotinamide and maintain NAD+ levels under changing metabolic conditions. The relative contribution of each route varies by tissue, species, and physiological state, and it remains an active area of research.
Research on NMN has expanded because NAD+ concentrations decline with age in some tissues and because NAD+ participates in energy metabolism, DNA repair, and signaling. Animal studies have reported changes in NAD+ levels after NMN administration, but human data are more limited and often focus on safety, pharmacokinetics, and biomarker changes. Questions remain about oral absorption, tissue distribution, and whether changes in blood NAD+ reflect changes inside specific organs. NMN is not an approved drug, and claims about its clinical effects should be distinguished from established biochemical findings.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide base with a ribose sugar and a phosphate group. Within cells, NMN sits on the biosynthetic route that recycles nicotinamide back into nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in redox reactions and signaling, enzymes that produce and consume it influence many metabolic processes. The compound is therefore best described as an intermediate rather than a final signaling molecule.
In the canonical salvage pathway, nicotinamide phosphoribosyltransferase, known as NAMPT, transfers a phosphoribosyl group to nicotinamide and releases NMN. A second enzyme, NMN adenylyltransferase, then attaches an adenylyl group to NMN to form NAD+. Alternative routes exist, including a pathway that uses nicotinamide riboside and its phosphorylated forms. The relative contribution of extracellular NMN to intracellular NAD+ pools remains an area of active investigation, and the roles of specific transporters and enzymes are not completely defined.
NMN is present in small amounts in various foods, including certain vegetables, fruits, and milk, though dietary quantities are generally low. Laboratory research often uses synthetic or enzymatically produced NMN. The compound has drawn interest because NAD+ levels decline with age in some tissues and because restoring NAD+ may affect metabolism in animal models. Whether oral NMN produces meaningful NAD+ increases in humans and whether such changes translate into health benefits are not fully established.
| Property | Value | Notes |
|---|---|---|
| Chemical formula | C11H15N2O8P | Pyridinium nucleotide; free acid form |
| Molar mass | 334.22 g/mol | Free acid; salt forms differ |
| Appearance | White to off-white powder | Typical reference material |
| Solubility class | Water-soluble | Hygroscopic under humid conditions |
| Common synonyms | Nicotinamide mononucleotide; NMN | Distinct from nicotinamide riboside |
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure consists of a nicotinamide ring linked to ribose phosphate, and the compound serves as an intermediate in the salvage pathway for nicotinamide adenine dinucleotide, or NAD+. In this pathway, nicotinamide phosphoribosyltransferase converts nicotinamide and phosphoribosyl pyrophosphate into NMN, after which NMN adenylyltransferase attaches an adenylate group to produce NAD+. Because NAD+ participates in redox reactions and signaling, NMN occupies a central position in cellular metabolism. The molecule is distinct from nicotinamide riboside, though the two are related in NAD+ precursor research.
Beyond its intracellular synthesis, NMN can be taken up from the extracellular environment, although the routes are still debated. Some evidence points to direct transport into cells through specific transporters, while other work suggests dephosphorylation to nicotinamide riboside followed by cellular uptake. Once inside, NMN can be converted to NAD+ by NMN adenylyltransferases; the relative contribution of these routes may differ by tissue, species, and experimental conditions. Researchers continue to investigate which mechanisms dominate in intact organisms and how they affect measured NAD+ levels. Direct measurement in tissues remains technically challenging because NMN can be rapidly metabolized during sample collection.
NMN occurs in many living systems, including bacteria, yeast, plants, and mammals. Dietary sources are present in foods such as edamame, avocado, broccoli, and various meats, but amounts vary widely and are generally lower than those used in research settings. Laboratory production often relies on enzymatic synthesis or chemical phosphorylation of nicotinamide riboside, and commercial material is typically supplied as a white to off-white powder. Because NMN is hygroscopic and sensitive to heat, moisture, and pH extremes, its handling requires care to preserve identity and purity. Aqueous preparation should be done with attention to pH and temperature to limit hydrolysis.
Inside cells, the enzyme nicotinamide phosphoribosyltransferase, or NAMPT, converts nicotinamide and a ribose-phosphate donor into NMN. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+. NAD+ participates in redox reactions and serves as a substrate for signaling enzymes such as sirtuins, PARPs, and CD38. Because NAD+ levels tend to decline with age in many organisms, NMN has drawn interest as a possible way to influence that decline. Whether oral NMN reliably raises NAD+ in human tissues, and whether any such change modifies disease risk, remain open research questions.
NMN is present in small amounts in some foods, including certain vegetables, fruits, and animal products, but food content varies widely and is not well standardized. In laboratory research, NMN is used as a tool compound to study NAD+ metabolism, mitochondrial function, and cellular stress responses. Animal studies have reported changes in NAD+ levels and various physiological measures after NMN administration, but species differences and study designs limit direct extrapolation to humans. Human trials have largely focused on safety, tolerability, and pharmacokinetics, with fewer studies examining clinical endpoints.
=== Opposition to retail reforms === Within a week of retail reform announcement, Indian government has faced a political backlash against its decision to allow competition and 51% ownership of multi-brand organised retail in India. Despite the fact that Salman Khurshid, India's law minister, claiming that many opposition parties, including the Bharatiya Janata Party, had privately encouraged the government to push through the retail reform, the intense criticism now targets Congress-led coalition government, and its decision to push through one of the biggest economic reforms in years for India. Opposition parties claim supermarket chains are ill-advised, unilateral and unwelcome. The opposition claims the entry of organised retailers would lead to their dominance that would decimate local retailers and force millions of people out of work. Mamata Banerjee, the chief minister of West Bengal and the leader of the Trinamool Congress, announced her opposition to retail reform, claiming "Some people might support it, but I do not support it. You see America is America … and India is India. One has to see what one's capacity is". Other states whose Chief Ministers have either personally announced opposition or announced reluctance to implement the retail reforms: Tamil Nadu, Uttar Pradesh, Bihar and Madhya Pradesh. Chief Ministers of many states have not made a personal statement in opposition or support of India needing retail reforms. Gujarat, Kerala, Karnataka and Rajasthan are examples of these states.
The jury really is still out on these bodies, whether they were aristocrats, priests, criminals, outsiders, whether they went willingly to their deaths or whether they were executed – but Lindow was a very remote place in those days, an unlikely place for an ambush or a murder According to Anne Ross, an archaeologist and scholar of Celtic history, and Don Robins, a chemist at the University of London, Lindow Man was likely a sacrifice victim of extraordinary importance. They identified his stomach contents as including the undigested remains of a partially burned barley griddle cake of a kind used by the ancient Celts to select victims for sacrifice. Such cakes were torn into fragments and placed in a sack, after which all candidates for sacrifice would withdraw a piece, with the one withdrawing the burnt piece being the one who would be sacrificed. They argued that Lindow Man was likely a high-ranking Druid who was sacrificed in a last-ditch effort to call upon the aid of three Celtic gods to stop a Roman offensive against the Celts in AD 60.
There were a few similar spark discharge experiments contemporaneous with Miller–Urey. An article in The New York Times (March 8, 1953) titled "Looking Back Two Billion Years" describes the work of Wollman M. MacNevin at Ohio State University, before the Miller Science paper was published in May 1953. MacNevin was passing 100,000V sparks through methane and water vapor and produced "resinous solids" that were "too complex for analysis." Furthermore, K. A. Wilde submitted a manuscript to Science on December 15, 1952, before Miller submitted his paper to the same journal in February 1953. Wilde's work, published on July 10, 1953, used voltages up to only 600V on a binary mixture of carbon dioxide (CO2) and water in a flow system and did not note any significant reduction products. According to some, the reports of these experiments explain why Urey was rushing Miller's manuscript through Science and threatening to submit to the Journal of the American Chemical Society. By introducing an experimental framework to test prebiotic chemistry, the Miller–Urey experiment paved the way for future origin of life research. In 1961, Joan Oró produced milligrams of the nucleobase adenine from a concentrated solution of HCN and NH3 in water. Oró found that several amino acids were also formed from HCN and ammonia under those conditions. Experiments conducted later showed that the other RNA and DNA nucleobases could be obtained through simulated prebiotic chemistry with a reducing atmosphere.
Sources: en.wikipedia.org
National Policy on Cooperatives was formulated in 2002 to develop the cooperative societies sector. The Ministry of Cooperation revised the old policy and launched National Cooperation Policy 2025. The new policy promotes the vision of 'Sahkar Se Samriddhi' (Prosperity through Cooperation) while contributing the India's long-term development agenda including its goal of becoming Vikshit Bharat by 2047.
== Further reading == The Folger Way: Coffee Pioneering Since 1850, by Ruth Waldo Newhall (1910–2003), married to Scott Newhall (1914–1992), late of the San Francisco Chronicle, J.A. Folger (publisher) (1961); OCLC 5838971
===== MeSH D08.811.682.047 – alcohol oxidoreductases ===== MeSH D08.811.682.047.050 – acetoin dehydrogenase MeSH D08.811.682.047.070 – alcohol dehydrogenase MeSH D08.811.682.047.150 – carbohydrate dehydrogenases MeSH D08.811.682.047.150.225 – fructuronate reductase MeSH D08.811.682.047.150.250 – galactose dehydrogenases MeSH D08.811.682.047.150.270 – glucose dehydrogenases MeSH D08.811.682.047.150.270.500 – glucose 1-dehydrogenase MeSH D08.811.682.047.150.300 – glucosephosphate dehydrogenase MeSH D08.811.682.047.150.600 – phosphogluconate dehydrogenase MeSH D08.811.682.047.150.650 – phosphoglycerate dehydrogenase MeSH D08.811.682.047.150.700 – sugar alcohol dehydrogenases MeSH D08.811.682.047.150.700.075 – aldehyde reductase MeSH D08.811.682.047.150.700.237 – d-xylulose reductase MeSH D08.811.682.047.150.700.400 – glycerolphosphate dehydrogenase MeSH D08.811.682.047.150.700.400.500 – glycerol-3-phosphate dehydrogenase (nad+) MeSH D08.811.682.047.150.700.437 – l-gulonolactone oxidase MeSH D08.811.682.047.150.700.475 – l-iditol 2-dehydrogenase MeSH D08.811.682.047.150.700.649 – mannitol dehydrogenase MeSH D08.811.682.047.150.900 – uridine diphosphate glucose dehydrogenase MeSH D08.811.682.047.180 – choline dehydrogenase MeSH D08.811.682.047.210 – galactose oxidase MeSH D08.811.682.047.239 – glucose oxidase MeSH D08.811.682.047.370 – homoserine dehydrogenase MeSH D08.811.682.047.370.060 – aspartokinase homoserine dehydrogenase MeSH D08.811.682.047.385 – 3-hydroxyacyl coa dehydrogenases MeSH D08.811.682.047.385.415 – hydroxymethylglutaryl coa reductases MeSH D08.811.682.047.385.415.250 – hydroxymethylglutaryl-coa reductases, nad-dependent MeSH D08.811.682.047.385.415.750 – hydroxymethylglutaryl-coa-reductases, nadp-dependent MeSH D08.811.682.047.393 – hydroxybutyrate dehydrogenase MeSH D08.811.682.047.428 – Hydroxyprostaglandin dehydrogenase MeSH D08.811.682.047.432 – hydroxypyruvate reductase MeSH D08.811.682.047.436 – hydroxysteroid dehydrogenases MeSH D08.811.682.047.436.174 – 11-beta-hydroxysteroid dehydrogenases MeSH D08.811.682.047.436.174.300 – 11-beta-hydroxysteroid dehydrogenase type 1 MeSH D08.811.682.047.436.174.600 – 11-beta-hydroxysteroid dehydrogenase type 2 MeSH D08.811.682.047.436.350 – 3-hydroxysteroid dehydrogenases MeSH D08.811.682.047.436.350.100 – 3alpha-hydroxysteroid dehydrogenase (B-specific) MeSH D08.811.682.047.436.350.150 – cholesterol oxidase MeSH D08.811.682.047.436.350.700 – progesterone reductase MeSH D08.811.682.047.436.375 – 17-hydroxysteroid dehydrogenases MeSH D08.811.682.047.436.375.280 – estradiol dehydrogenases MeSH D08.811.682.047.436.400 – 20-hydroxysteroid dehydrogenases MeSH D08.811.682.047.436.400.074 – 20alpha-hydroxysteroid dehydrogenase MeSH D08.811.682.047.436.400.150 – cortisone reductase MeSH D08.811.682.047.485 – imp dehydrogenase MeSH D08.811.682.047.497 – isocitrate dehydrogenase MeSH D08.811.682.047.500 – 3-isopropylmalate dehydrogenase MeSH D08.811.682.047.524 – ketol-acid reductoisomerase MeSH D08.811.682.047.551 – lactate dehydrogenases MeSH D08.811.682.047.551.249 – epsilon-crystallins MeSH D08.811.682.047.551.400 – l-lactate dehydrogenase MeSH D08.811.682.047.551.500 – l-lactate dehydrogenase (cytochrome) MeSH D08.811.682.047.605 – malate dehydrogenase MeSH D08.811.682.047.748 – malate dehydrogenase (nadp+) MeSH D08.811.682.047.892 – xanthine dehydrogenase MeSH D08.811.682.047.928 – xanthine oxidase
Sources: en.wikipedia.org
These peptides result from partial proteolysis of intracellular or extracellular protein precursors performed by several processing enzymes or protease complexes (rennin, kallikreins, calpains, prohormone convertases, proteasomes, endosomes, lysosomes), which convert proteins into peptides, including those with biological activities. The resulting protein fragments of various sizes are either readily degraded into free amino acids, or captured by oligopeptidases, whose peculiar binding and/or catalytic properties allow them to fulfill their physiological roles by trimming inactive peptide precursors leading to their active form, converting bioactive peptides into novel ones., inactivating them, thus restraining the continuous activation of specific receptors, or protecting the newly generated bioactive peptide from further degradation, suggesting a peptide chaperon-like activity. TOP, a ubiquitous cytosolic oligopeptidase, is a remarkable example of how this enzyme could play an essential role in immune defense against cancer cells. It has also been successfully used as a hook to fish novel bioactive peptides from cytosol of cells. The involvement of peptides in cell-cell interactions and in neuropsychiatric, autoimmune, and neurovegetative diseases are waiting for peptidomics and gene silencing approaches, which will expedite the formation of new concepts in an emerging era for oligopeptidases. The participation of oligopeptidases in a number of pathologies has long been reported.
Ions with the same electron configuration decrease in size as their atomic number rises, due to increased attraction from the more positively charged nucleus: thus for example ionic radii decrease in the series Se2−, Br−, Rb+, Sr2+, Y3+, Zr4+, Nb5+, Mo6+, Tc7+. Ions of the same element get smaller as more electrons are removed, because the attraction from the nucleus begins to outweigh the repulsion between electrons that causes electron clouds to expand: thus for example ionic radii decrease in the series V2+, V3+, V4+, V5+.
== Preparations == The Gemini 4 spacecraft completed major manufacturing activity, module tests, and equipment installation at McDonnell at the end of January 1965. The spacecraft was mated to the Titan II launch vehicle at Cape Canaveral Launch Complex 19 on April 23, 1965. Final system tests were performed over several additional weeks. NASA leadership approved the Gemini 4 EVA plan on May 25, 1965; the public was informed on the same day
Global use of nickel is currently 68% in stainless steel, 10% in nonferrous alloys, 9% electroplating, 7% alloy steel, 3% foundries, and 4% other (including batteries). Nickel is used in many recognizable industrial and consumer products, including stainless steel, alnico magnets, coinage, rechargeable batteries (e.g. nickel–iron), electric guitar strings, microphone capsules, plating on plumbing fixtures, and special alloys such as permalloy, elinvar, and invar. It is used for plating and as a green tint in glass. Nickel is preeminently an alloy metal, and its chief use is in nickel steels and nickel cast irons, in which it typically increases the tensile strength, toughness, and elastic limit. It is widely used in many other alloys, including nickel brasses and bronzes and alloys with copper, chromium, aluminium, lead, cobalt, silver, and gold (Inconel, Incoloy, Monel, Nimonic). Nickel is traditionally used for Kris production in Southeast Asia.
Sources: en.wikipedia.org
NMN stands for nicotinamide mononucleotide. It is a naturally occurring nucleotide and an intermediate in the cellular production of NAD+.
No. NMN is a smaller precursor molecule, while NAD+ is a dinucleotide cofactor used in many reactions. Enzymes called NMNAT convert NMN into NAD+ inside cells.
This question is not fully settled. Some evidence suggests NMN may be dephosphorylated to nicotinamide riboside before uptake, while other studies propose direct transport. Tissue-specific handling in humans remains an open research area.
NMN is nicotinamide mononucleotide, a nucleotide intermediate in NAD+ biosynthesis. It occurs naturally in cells and is also produced commercially as a supplement ingredient.